REBOOT | For people with Membranous Nephropathy
An NIH-sponsored clinical trial for people with primary membranous nephropathy
Developing, funding and conducting clinical trials in immune tolerance
Developing, funding and conducting clinical trials in immune tolerance
An NIH-sponsored clinical trial for people with primary membranous nephropathy
A clinical trial evaluating belimumab with rituximab for primary membranous nephropathy.
If you are between the ages of 18-75 and have been diagnosed with primary membranous nephropathy, you may be eligible to participate.